Christopher Patusky - Director, United Therapeutics Corp

As of November 12, 2021


Christopher Patusky Net Worth

  • Net worth is estimated to be at least $18.95M
  • Owns at least 2,880 units of United Therapeutics Corp stock
  • Sold an estimated value of $26.96M in the last 18 years at United Therapeutics Corp

Christopher Patusky Trading

  • Largest purchase of shares was 7,500 units , worth over $388.27K on February 27, 2015
  • Largest sale of shares was 7,500 units , worth over $1.16M on February 27, 2015
  • In total has made about 96 transactions over 18 years
  • Usually trades in June, with the busiest year in 2010
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

United Therapeutics Corp Insider Trading

  • The most recent transaction was 3,083 units sold on November 29, 2021 by Martine Rothblatt worth over $618.57K
  • In the last 18 years, insiders at United Therapeutics Corp sold an estimated value of $1.26B and bought an estimated value of $459.25M
  • The most active traders are Martine Rothblatt, Chairperson & CEO,  Paul Mahon, EVP & General Counsel,  and Roger Jeffs
  • Insider trading is most common in June, with the busiest year in 2015

UNITED THERAPEUTICS Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1